医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

De Novo Versus Recurrent HER2‐Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry

广告
第一作者: Tripathy Debu
作者单位: Department of Medical Oncology, Baylor University Medical Center, Texas Oncology and U.S [1] David Geffen School of Medicine, University of California Los AngelesLos Angeles,California,USA [2] Florida Precision Oncology, a division of 21st Century OncologyBoca Raton,Florida,USA [3] Breast Oncology, Division of Hematology/Oncology, University of Vermont Cancer Center, University [4] Personalized Healthcare, Product Development, Genentech, Inc.South San Francisco,California,USA [5] Sarah Cannon Research Institute and Tennessee OncologyNashville,Tennessee,USA [6] Georgetown Lombardi Comprehensive Cancer Center, Georgetown UniversityWashington,DC,USA [7] U.S. Medical Affairs, F. Hoffmann‐La RocheMississauga,Ontario,Canada [8] Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD [9] Helen Diller Family Comprehensive Cancer Center, University of California San FranciscoSan [10] U.S. Medical Affairs, Genentech, Inc.South San Francisco,California,USA [11] Inflammatory Breast Cancer Research FoundationWest Lafayette,Indiana,USA [12] Department of Internal Medicine, Rush University Medical CenterChicago,Illinois,USA [13] Hillman Cancer Center, University of Pittsburgh Medical CenterPittsburgh,Pennsylvania,USA [14]
发布时间 2020-10-22
提交
  • 浏览0
The oncologist

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷